Skip to main content

Table 1 Baseline characteristics and outcomes of patients treated for peritoneal carcinomatosis (N = 101)

From: Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)

Characteristic Mean (SD) Frequency n (%)
Age of primary diagnosis in years   
Mean 52.3 (13.4)  
Sex   
Male   49 (48.5)
Female   52 (51.5)
Primary Tumor Diagnosis   
Appendiceal   48 (47.5)
Colorectal   34 (33.7)
Gastric   7 (6.9)
Ovarian   3 (3.0)
Sarcoma   3 (3.0)
Others   6 (5.9)
Grade of primary tumor (n = 85)   
Grade 1 (Well differentiated)   36 (42.9)
Grade 2 (Moderately differentiated)   23 (27.4)
Grade 3 (Poorly differentiated/signet ring)   25 (29.8)
Preoperative imaging   
Computed tomography (CT) scan   89 (88.1)
Magnetic resonance imaging (MRI) scan   41 (40.6)
Positron emission tomography (PET) scan   62 (69.7)
Intraoperative PCI score (n = 74) 15.5 (11.7)  
HIPEC completed   73 (72.3)
Completeness of cytoreduction (n = 65)   
CC0   52 (80.0)
CC1   9 (13.9)
CC2   4 (6.2)
Length of stay 11.3 (9.1)  
Grade 3 to 5 complications   15 (20.5)
Chemotherapy received   46 (45.5)
Before CRS   16 (34.8)
After CRS   19 (41.3)
Both before and after CRS   11 (23.9)
Patients alive and under follow up   82 (81.2)
Status at last office visit (n = 82)   
No disease   31 (37.8)
Stable disease   24 (29.3)
Progressive disease   27 (32.9)
  1. CRS, cytoreductive surgery; HIPEC, hyperthermic intraperitoneal chemotherapy; PCI, peritoneal carcinomatosis index.